Literature DB >> 7128757

The pharmacokinetics of VIP in dog and pig.

S J Mitchell, I M Modlin, A A D'Sa Barros, S R Bloom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128757     DOI: 10.1007/bf01955385

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  11 in total

1.  Lack of hepatic inactivation of canine vasoactive intestinal peptide.

Authors:  U T Strunz; J H Walsh; S R Bloom; M R Thompson; M I Grossman
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

2.  Intestinal secretion: stimulation by peptides.

Authors:  G O Barbezat; M I Grossman
Journal:  Science       Date:  1971-10-22       Impact factor: 47.728

3.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

4.  Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

Authors:  M G Bryant; M M Polak; I Modlin; S R Bloom; R H Albuquerque; A G Pearse
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

5.  Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves.

Authors:  L I Larsson; L Edvinsson; J Fahrenkrug; R Håkanson; C Owman; O Schaffalitzky de Muckadell; F Sundler
Journal:  Brain Res       Date:  1976-08-27       Impact factor: 3.252

6.  Changes in the concentration of vasoactive intestinal peptide in intestinal lymph in response to vagal stimulation in the calf.

Authors:  A V Edwards; P M Birchman; S J Mitchell; S R Bloom
Journal:  Experientia       Date:  1978-09-15

7.  Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract.

Authors:  J Fahrenkrug; H Galbo; J J Holst; O B Schaffalitzky de Muckadell
Journal:  J Physiol       Date:  1978-07       Impact factor: 5.182

8.  Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.

Authors:  S Domschke; W Domschke; S R Bloom; P Mitznegg; S J Mitchell; G Lux; U Strunz
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

9.  Proceedings: The distribution of vasoactive intestinal peptide (VIP) in the primate gastrointestinal tract and characterization of VIP from human tumours.

Authors:  S R Bloom; M G Bryant
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

10.  Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia.

Authors:  I M Modlin; S R Bloom; S Mitchell
Journal:  Experientia       Date:  1978-04-15
View more
  1 in total

1.  Relaxation of cat tracheobronchial and pulmonary arterial smooth muscle by vasoactive intestinal peptide: lack of influence by peptidase inhibitors.

Authors:  R J Altiere; L Diamond
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.